Cellular & Molecular Biology Basics for Orthopaedics

The eukaryotic cell compartmentalises its work. The nucleus stores DNA and is the site of transcription; the rough endoplasmic reticulum, studded with ribosomes, synthesises secreted and membrane proteins; the smooth ER handles lipids and calcium; the Golgi apparatus modifies, sorts and packages proteins; mitochondria generate ATP and release factors that trigger intrinsic apoptosis; and lysosomes degrade material with acid hydrolases. In musculoskeletal tissue these are specialised: chondrocytes and osteoblasts have prominent rough ER and Golgi to manufacture and secrete the collagen-rich extracellular matrix, while the osteoclast is a multinucleated cell that resorbs bone using lysosomal enzymes (and acid) delivered at its ruffled border.

A cell-biology primer for orthopaedics needs the mesenchymal stem/stromal cell (MSC) — the multipotent progenitor of the musculoskeletal lineages:

• Sources: bone marrow (the classic), periosteum, adipose tissue, muscle and synovium.
• Trilineage differentiation: the defining capacity to become osteoblast, chondrocyte and adipocyte (also tenocyte/myocyte).
• Master lineage transcription factors: Runx2 (with Osterix/SP7) drives the osteoblast line, Sox9 the chondrocyte line, and PPAR-gamma the adipocyte line — competing programmes from one progenitor (the osteoblast-vs-adipocyte switch matters in ageing/osteoporosis).
• Identity (ISCT criteria): plastic-adherent, trilineage-capable, surface markers positive for CD73/CD90/CD105 and negative for haematopoietic markers (CD34/CD45).
• Why orthopaedics cares: periosteal and marrow MSCs are the cellular engine of fracture healing, the osteogenic component of bone grafts, and the basis of cartilage/tendon repair and cell therapy - all developed on stem cells and MSCs in orthopaedics.

Dividing cells progress through interphase — G1 (growth), S (DNA synthesis/replication), G2 (growth/preparation) — and then M (mitosis); non-dividing cells rest in G0. Progression is driven by cyclins and cyclin-dependent kinases (CDKs) and policed at checkpoints (principally G1/S and G2/M) that verify DNA integrity and replication before the cell commits. The tumour suppressors p53 (the "guardian of the genome", which arrests the cycle or triggers apoptosis when DNA is damaged) and Rb are central. Loss of cell-cycle control — through oncogene activation or tumour-suppressor loss — is the basis of oncogenesis, relevant to bone and soft-tissue tumours.

Genetic information flows DNA → RNA → protein. In the nucleus, a gene's DNA is transcribed by RNA polymerase into messenger RNA (mRNA), which is processed (splicing, capping, poly-A tail) and exported to the cytoplasm. There, ribosomes translate the mRNA codons into a chain of amino acids, using transfer RNA. The polypeptide then folds and undergoes post-translational modification into a functional protein. A mutation at any point yields an abnormal protein and disease — the molecular basis of many orthopaedic conditions: COL1A1/COL1A2 (osteogenesis imperfecta), FGFR3 (achondroplasia), COMP (pseudoachondroplasia/MED), EXT1/2 (multiple hereditary exostoses).

The dogma gives the flow; these techniques interrogate each step and are examinable basic science:

• DNA: PCR amplifies a target sequence (qPCR quantifies; RT-PCR starts from RNA); the Southern blot detects a DNA sequence; Sanger and next-generation sequencing (NGS) read the sequence (sarcoma gene panels, germline dysplasia testing).
• RNA: the Northern blot and RT-qPCR measure gene expression.
• Protein: the Western blot (size-separated, antibody-detected), ELISA (quantifies a protein/antibody), and immunohistochemistry (IHC) (localises a protein in a tissue section — tumour markers). (Blot mnemonic: SNoW DRoP — Southern=DNA, Northern=RNA, Western=Protein.)
• Cytogenetics: the karyotype and FISH detect translocations/amplifications.
• Orthopaedic applications: detecting sarcoma fusion genes (e.g. EWSR1–FLI1 in Ewing sarcoma by RT-PCR / FISH break-apart; SS18–SSX in synovial sarcoma; MDM2 amplification in atypical lipomatous tumour / parosteal osteosarcoma by FISH), IHC markers (CD99 in Ewing, SATB2 for osteoblastic lesions), and broad-range 16S rRNA PCR for organism detection in culture-negative prosthetic joint infection. The two fusion-gene examples have their own pages - Ewing sarcoma and synovial sarcoma - and are worth reading beside this section, because they are where an abstract assay becomes the thing that names the tumour.

Collagen is the dominant structural protein of the musculoskeletal system and the best orthopaedic example of protein synthesis and post-translational modification:

1. Transcription/translation of pro-alpha chains on the rough ER, each with the repeating glycine-X-Y sequence (X often proline, Y often hydroxyproline).
2. Hydroxylation of proline and lysine residues — which requires VITAMIN C as a cofactor. Its lack is scurvy, where the failure is at THIS single step: the chains are made but cannot be stabilised, so what is secreted is under-hydroxylated and mechanically useless - which is why the disease shows up as bleeding, poor healing and, in the child, a radiographically distinctive metaphysis.
3. Glycosylation and assembly of three chains into the triple helix (procollagen).
4. Secretion, then cleavage of the propeptides to form tropocollagen.
5. Fibril assembly and CROSS-LINKING (lysyl oxidase) for tensile strength.

There are 28 collagen types; the fibrillar collagens (types I, II, III, V, XI...) build the load-bearing frameworks. Type I predominates in bone, tendon and skin; type II in hyaline cartilage.

Cells coordinate via chemical signals classified by range: endocrine (hormones via the bloodstream, e.g. PTH, oestrogen), paracrine (local diffusion to neighbours, e.g. growth factors in fracture healing), autocrine (a cell signalling itself), and juxtacrine/direct contact (e.g. Notch). Signals bind receptors (cell-surface or intracellular) and trigger intracellular cascades (second messengers, kinases, transcription factors) that change gene expression — the machinery behind the bone-signalling pathways (Wnt, RANK–RANKL–OPG, BMP/TGF-beta, Hedgehog, Notch).